Burling Wealth Partners invested nearly $7.1 million in AbbVie in 2019, despite recent market adjustments.

In 2019, Burling Wealth Partners LLC invested $7,091,000 in AbbVie Inc., acquiring 39,906 shares. Despite a 24.3% increase in stock value, AbbVie missed earnings expectations. PineBridge Investments L.P. and Voya Investment Management LLC have since reduced their holdings. AbbVie has a market cap of $313.60 billion and is rated a "Moderate Buy" by analysts with a consensus price target of $211.19.